Acurx Pharmaceuticals, Inc.Insider Ownership
|
|
Current Insider Ownership
Log in to see the full results
Login or create a free CapEdge account to unlock the rest of this table.
| Luci David P | President and CEO | Common StockStock OptionWarrants for Common Stock | Jan 6, 2025Apr 20, 2026Jan 6, 2025 | 1,097,458667,10049,261 | 69.2442.093.11 | 1,777,8821,080,70279,803 |
| Deluccia Robert J | Director | Common StockStock OptionWarrants for Common Stock | Jan 6, 2025Apr 20, 2026Jan 6, 2025 | 1,010,196667,10049,261 | 63.7442.093.11 | 1,636,5181,080,70279,803 |
| Sailer Carl | Director | Common StockStock OptionWarrants for Common Stock | Jan 6, 2025Apr 20, 2026Jan 6, 2025 | 137,18324,15024,631 | 8.661.521.55 | 222,23639,12339,902 |
Insider Trading Trends
Insider Transactions
Voluntary Buys vs Sells
You need to login to see this data
Historical Insider Trading (3-Years)
10b5-1
Log in to see the full results
Login or create a free CapEdge account to unlock the rest of this table.
| Sailer Carl | Common Stock | No | No | Grant | ACQUIRE A | 2.36 | +2,150 | 5,074 | 2,150 | Apr 20, 2026 | |
| Luci David P | Common Stock | No | No | Grant | ACQUIRE A | 2.36 | +37,100 | 87,556 | 37,100 | Apr 20, 2026 | |
| Dean Jack H | Common Stock | No | No | Grant | ACQUIRE A | 2.36 | +2,150 | 5,074 | 2,150 | Apr 20, 2026 | |